Bucheon, South Korea

Sung Han Kim

This inventor holds 1 USPTO granted patent. Top assignee: Digital Genomics Inc.. Active years: 2011.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Sung Han Kim. Retrieved from https://idiyas.com/inventor/sung-han-kim-yn24or9b

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2011

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations in Lung Cancer Diagnosis by Sung Han Kim

Introduction

Sung Han Kim is an accomplished inventor based in Buchcon-si, South Korea. He has made significant contributions to the field of medical diagnostics, particularly in the area of lung cancer detection. His innovative work has the potential to improve early diagnosis and treatment options for patients.

Latest Patents

Sung Han Kim holds a patent for "Markers for the diagnosis of lung cancer." This patent discloses a diagnostic marker that is specific for lung cancer. The invention also includes a composition and a kit that comprises an agent for measuring the presence of the marker. Furthermore, it outlines a method for diagnosing lung cancer using the composition or kit. He has 1 patent to his name.

Career Highlights

Sung Han Kim is currently associated with Digital Genomics Inc., where he continues to work on innovative solutions in genomics and diagnostics. His expertise in the field has positioned him as a valuable asset to the company and the medical community.

Collaborations

Some of his notable coworkers include Jeong Ho Yoon and Se Nyun Kim. Their collaborative efforts contribute to the advancement of research and development in the field of genomics.

Conclusion

Sung Han Kim's work in developing diagnostic markers for lung cancer represents a significant advancement in medical technology. His contributions are vital for improving patient outcomes and enhancing the accuracy of lung cancer diagnosis.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…